Edition:
United States

Vical Inc (VICL.OQ)

VICL.OQ on NASDAQ Stock Exchange Capital Market

2.36USD
4:00pm EDT
Change (% chg)

$0.00 (+0.00%)
Prev Close
$2.36
Open
$2.37
Day's High
$2.37
Day's Low
$2.35
Volume
4,296
Avg. Vol
16,125
52-wk High
$4.79
52-wk Low
$2.06

VICL.OQ

Chart for VICL.OQ

About

Vical Incorporated researches and develops biopharmaceutical products based on its deoxyribonucleic acid (DNA) delivery technologies for the prevention and treatment of life-threatening diseases. The Company has approximately four active, independent, or partnered development programs in the areas of infectious disease including... (more)

Overall

Beta: 2.26
Market Cap(Mil.): $26.19
Shares Outstanding(Mil.): 11.10
Dividend: --
Yield (%): --

Financials

  VICL.OQ Industry Sector
P/E (TTM): -- 141.29 17.43
EPS (TTM): -0.88 -- --
ROI: -21.75 2.17 -5.41
ROE: -21.81 0.10 -4.69

BRIEF-Vical Q1 loss per share $0.25

* Vical had cash and investments of $39.2 million at March 31, 2017

May 15 2017

BRIEF-Vical reports outcome of Phase 1 trial of VL-2397

* Vical highlights successful outcome of Phase 1 trial of VL-2397 novel antifungal during its research and development day Source text for Eikon: Further company coverage:

May 02 2017

BRIEF-AnGes MG plans cooperation with Vical Inc on development of genetic medication for Chronic Hepatitis B

* Says co enters into a cooperation contract with a US-based firm Vical Incorporated, on joint development of genetic medication for treatment of Chronic Hepatitis B

Apr 04 2017

BRIEF-Vical reports Q4 revenue of $3.2 million

* Vical Inc- Company is projecting net cash burn for 2017 between $8 million and $11 million Source text for Eikon: Further company coverage:

Mar 09 2017

More From Around the Web

Competitors

  Price Chg
Sanofi SA (SASY.PA) €87.74 +0.43
Novartis AG (NOVN.S) CHF78.60 -0.50
GlaxoSmithKline plc (GSK.L) 1,643.50 +25.50
AstraZeneca plc (AZN.L) 5,227.00 +18.00
Merck & Co., Inc. (MRK.N) $64.92 -0.12
Pfizer Inc. (PFE.N) $32.14 -0.02
Roche Holding Ltd. (ROG.S) CHF266.60 -0.60
Roche Holding Ltd. (RO.S) CHF267.75 +0.25
Genocea Biosciences Inc (GNCA.OQ) $5.90 -0.04
Agenus Inc (AGEN.OQ) $3.45 -0.05

Earnings vs. Estimates